Literature DB >> 1752096

SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastases.

L C Swayne1, D M Goldenberg, W L Diehl, R D Macaulay, L A Derby, J Z Trivino.   

Abstract

Radioimmunodetection (RAID) using Tc-99m labeled Fab' fragments of the anti-CEA monoclonal antibody IMMU-4 was performed in a 68-year-old man for preoperative evaluation of colonic metastases. Planar images at 3 and 18 hours showed uptake within known metastases in the left lobe of the liver that had been observed with CT and at surgery during the preceding month. SPECT images at 3 hours demonstrated two additional unsuspected lesions. All sites were surgically confirmed the following day using intraoperative sonographic guidance, with the smallest occult lesion measuring only 6 x 9 mm. This case illustrates the limitations of CT and surgery, the potential of RAID for the detection of occult metastases, the increased sensitivity of SPECT over planar images for detecting lesions less than 1 cm in diameter, and the value of intraoperative guidance for small nonpalpable lesions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752096     DOI: 10.1097/00003072-199111000-00011

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Fábio G Campos; Wladimir Nadalin; Desiderio Kiss; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

2.  [Primary pleomorphic rhabdomyosarcoma of the liver].

Authors:  U Meyer-Pannwitt; K Kummerfeldt; C E Broelsch
Journal:  Langenbecks Arch Chir       Date:  1996

3.  Pretargeted molecular imaging and radioimmunotherapy.

Authors:  David M Goldenberg; Chien-Hsing Chang; Edmund A Rossi; William J; Robert M Sharkey
Journal:  Theranostics       Date:  2012-05-17       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.